ADHD: Controversy, Key Research Findings, Rising Prevalence, and Promise

Tuesday, January 12, 2021
ADHD: Controversy, Key Research Findings, Rising Prevalence, and Promise

Dr. Stephen Hinshaw will discuss the many controversies surrounding attention-deficit hyperactivity disorder (ADHD), basing the presentation in scientific findings rather than the myths that so often surround the topic. Included will be processes underlying ADHD, prevalence in males vs. females, risk for long-term impairments, the role of school policies in predicting rising rates of diagnosis, and a brief summary of effective treatments.

Watch webinar recording:

Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.

Sign up for other upcoming webinars.

View past webinar recordings.

Presented by 
Stephen P. Hinshaw, Ph.D.
Stephen P. Hinshaw, Ph.D.
The University of California, San Francisco / The University of California, Berkeley

Professor of Psychiatry and Vice-Chair for Child and Adolescent Psychology

Professor of Psychology

2019 Ruane Prize for Outstanding Achievement in Child & Adolescent Psychiatry Research

 

Dr. Stephen Hinshaw received his A.B. from Harvard (summa cum laude) in 1974 and his Ph.D. in clinical psychology from UCLA in 1983. He completed his postdoctoral fellowship at the Langley Porter Institute of the University of California, San Francisco, in 1985. His scholarship focuses on developmental psychopathology, multimodal treatment strategies for youth with externalizing disorders (focusing on the family and peer-related processes that produce optimal change), and mental illness stigma. He has authored over 360 articles and chapters plus 12 books, including (with Richard Scheffler) The ADHD Explosion: Myths, Medication, Money, and Today’s Push for Performance (Oxford University Press, 2014), and (as sole author) Another Kind of Madness: A Journey through the Stigma and Hope of Mental Illness (St. Martin’s Press, 2017).

Dr. Hinshaw's research focuses on evidence-based assessment and treatment of youth with attention deficit hyperactivity disorder (ADHD) and related disruptive behaviors, the interplay of neurobiological vulnerability and environmental contexts (especially parenting practices and peer relationships) in explaining the onset and maintenance of such conditions, and the contribution of deficits in executive function to later maladjustment. Through a multilayered program of work he has altered the field’s fundamental perspective from a narrow focus on symptoms and heritability to a broader view of context, development, and competencies. He is the world’s leader in investigating girls and women with ADHD. His Berkeley Girls with ADHD Longitudinal Study (BGALS) is the largest such investigation. Among the key findings: the major risk for self-injury in girls with ADHD as they mature into adulthood, explained in part by factors like poor response inhibition, peer rejection, and early trauma.

Moderated by 
Jeffrey Borenstein, M.D.
Brain & Behavior Research Foundation

President and CEO

 

Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein also serves as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.